ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SERGIO ROVNER M.D.

Endocrinology, Diabetes Metabolism

11,645

$2.21M

907
620 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$190
Average prescription price

Avg: $149

LARRY WHITFIELD MD

Endocrinology, Diabetes Metabolism

11,222

$874K

459
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 48%

$78
Average prescription price

Avg: $149

JACQUELINE COHN M.D.

Endocrinology, Diabetes Metabolism

11,201

$1.03M

737
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 48%

$92
Average prescription price

Avg: $149

SUMANA GANGI M.D

Endocrinology, Diabetes Metabolism

10,648

$1.44M

904
561 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 48%

$135
Average prescription price

Avg: $149

MARCEL TWAHIRWA MD

Endocrinology, Diabetes Metabolism

10,435

$2.35M

967
646 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 48%

$225
Average prescription price

Avg: $149

JEHANARA AHMED M.D.

Endocrinology, Diabetes Metabolism

10,230

$1.13M

816
584 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$111
Average prescription price

Avg: $149

WILLIAM TRIGOSO MD

Endocrinology, Diabetes Metabolism

9,340

$1.53M

859
595 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$164
Average prescription price

Avg: $149

JOSE ZAVALETA M.D.

Endocrinology, Diabetes Metabolism

9,213

$1.25M

611
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 48%

$136
Average prescription price

Avg: $149

LEONARD DODSON M.D.

Endocrinology, Diabetes Metabolism

8,072

$782K

350
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 48%

$97
Average prescription price

Avg: $149

STEVEN FEHRENKAMP MD

Endocrinology, Diabetes Metabolism

7,879

$1.07M

558
406 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 48%

$136
Average prescription price

Avg: $149

KANDASWAMY JAYARAJ M.D.

Endocrinology, Diabetes Metabolism

7,603

$1.18M

681
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 48%

$155
Average prescription price

Avg: $149

JOSE ORTIZ M.D.,F.A.C.E.

Endocrinology, Diabetes Metabolism

7,481

$1.25M

592
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 48%

$167
Average prescription price

Avg: $149

CARLOS ARAUZ PACHECO MD

Endocrinology, Diabetes Metabolism

7,299

$947K

614
427 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 48%

$130
Average prescription price

Avg: $149

GALO RODARTE M.D.

Endocrinology, Diabetes Metabolism

7,213

$727K

336
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 48%

$101
Average prescription price

Avg: $149

JOSE BECEIRO MD

Endocrinology, Diabetes Metabolism

7,195

$864K

553
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 48%

$120
Average prescription price

Avg: $149

FREDERICK RUSHFORD M.D.

Endocrinology, Diabetes Metabolism

7,161

$1.59M

536
463 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 48%

$221
Average prescription price

Avg: $149

MICHAEL MACADAMS M.D.

Endocrinology, Diabetes Metabolism

7,159

$1.01M

722
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 48%

$142
Average prescription price

Avg: $149

NELSON LUM M.D.

Endocrinology, Diabetes Metabolism

6,940

$806K

491
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 48%

$116
Average prescription price

Avg: $149

ALEJANDRO PLAN M.D.

Endocrinology, Diabetes Metabolism

6,834

$857K

488
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 48%

$125
Average prescription price

Avg: $149

SHERWYN SCHWARTZ

Endocrinology, Diabetes Metabolism

6,690

$1.06M

575
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 48%

$158
Average prescription price

Avg: $149

FIRAS AKHRASS MD

Endocrinology, Diabetes Metabolism

6,640

$1.31M

664
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 48%

$198
Average prescription price

Avg: $149

TOM THOMAS DO

Endocrinology, Diabetes Metabolism

6,368

$748K

444
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 48%

$117
Average prescription price

Avg: $149

ROBERT HOOD M.D.,F.R.C.P.C.

Endocrinology, Diabetes Metabolism

6,272

$1.22M

514
408 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 48%

$195
Average prescription price

Avg: $149

BHASKAR ROY M.D.

Endocrinology, Diabetes Metabolism

6,158

$634K

420
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 48%

$103
Average prescription price

Avg: $149

THOMAS BLEVINS M.D.

Endocrinology, Diabetes Metabolism

6,147

$954K

690
572 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 48%

$155
Average prescription price

Avg: $149

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank